메뉴 건너뛰기




Volumn 6, Issue 1, 2014, Pages

Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

Author keywords

3 deazaneplanocin A; 5 aza 2' deoxcytidine; Decitabine; Epigenetic therapy; EZH2; Histone deacetylase inhibitors; Myeloid leukemia

Indexed keywords

3 DEAZANEPLANOCIN A; DECITABINE; HISTONE; HISTONE DEACETYLASE; TRICHOSTATIN A;

EID: 84932160214     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-6-19     Document Type: Article
Times cited : (60)

References (47)
  • 1
    • 40849139208 scopus 로고    scopus 로고
    • Epigenetics in cancer
    • Esteller M: Epigenetics in cancer. N Engl J Med 2008, 358: 1148-1159.
    • (2008) N Engl J Med , vol.358 , pp. 1148-1159
    • Esteller, M.1
  • 2
    • 80053144962 scopus 로고    scopus 로고
    • A decade of exploring the cancer epigenomebiological and translational implications
    • Baylin SB, Jones PA: A decade of exploring the cancer epigenomebiological and translational implications. Nat Rev Cancer 2011, 11: 726-734.
    • (2011) Nat Rev Cancer , vol.11 , pp. 726-734
    • Baylin, S.B.1    Jones, P.A.2
  • 6
    • 77449149374 scopus 로고    scopus 로고
    • Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia
    • Cashen AF, Schiller GJ, O’Donnell MR, DiPersio JF: Multicenter, phase II study of decitabine for the first-line treatment of older patients with acute myeloid leukemia. J Clin Oncol 2010, 28: 556-561.
    • (2010) J Clin Oncol , vol.28 , pp. 556-561
    • Cashen, A.F.1    Schiller, G.J.2    O’Donnell, M.R.3    DiPersio, J.F.4
  • 9
    • 84869003466 scopus 로고    scopus 로고
    • Epigenetic therapy leaps ahead with specific targeting of EZH2
    • Melnick A: Epigenetic therapy leaps ahead with specific targeting of EZH2. Cancer Cell 2012, 22: 569-570.
    • (2012) Cancer Cell , vol.22 , pp. 569-570
    • Melnick, A.1
  • 10
    • 77956222562 scopus 로고    scopus 로고
    • Polycomb group proteins: Multi-faceted regulators of somatic stem cells and cancer
    • Sauvageau M, Sauvageau G: Polycomb group proteins: Multi-faceted regulators of somatic stem cells and cancer. Cell Stem Cell 2010, 7: 299-313.
    • (2010) Cell Stem Cell , vol.7 , pp. 299-313
    • Sauvageau, M.1    Sauvageau, G.2
  • 11
    • 79956145260 scopus 로고    scopus 로고
    • Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: Relation to adverse epigenetic alteration and poor prognostic scoring
    • Xu F, Li X, Wu L, Zhang Q, Yang R, Yang Y, Zhang Z, He Q, Chang C: Overexpression of the EZH2, RING1 and BMI1 genes is common in myelodysplastic syndromes: relation to adverse epigenetic alteration and poor prognostic scoring. Ann Hematol 2011, 90: 643-653.
    • (2011) Ann Hematol , vol.90 , pp. 643-653
    • Xu, F.1    Li, X.2    Wu, L.3    Zhang, Q.4    Yang, R.5    Yang, Y.6    Zhang, Z.7    He, Q.8    Chang, C.9
  • 13
    • 84856746717 scopus 로고    scopus 로고
    • Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease
    • Herrera-Merchan A, Arranz L, Ligos JM, de Molina A, Dominguez O, Gonzalez S: Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat Commun 2012, 3: 623.
    • (2012) Nat Commun , vol.3 , pp. 623
    • Herrera-Merchan, A.1    Arranz, L.2    Ligos, J.M.3    De Molina, A.4    Dominguez, O.5    Gonzalez, S.6
  • 18
    • 84862556419 scopus 로고    scopus 로고
    • Synergistic antileukemic action of inhibitors of DNA methylation and histone methylation
    • Momparler RL, Idaghdour Y, Marquez VE, Momparler LF: Synergistic antileukemic action of inhibitors of DNA methylation and histone methylation. Leukemia Res 2012, 36: 1049-1054.
    • (2012) Leukemia Res , vol.36 , pp. 1049-1054
    • Momparler, R.L.1    Idaghdour, Y.2    Marquez, V.E.3    Momparler, L.F.4
  • 19
    • 67449127083 scopus 로고    scopus 로고
    • Cytotoxicity mediated by histone deacetylases inhibitors in cancer cells: Mechanisms and potential clinical implications
    • Schrump DS: Cytotoxicity mediated by histone deacetylases inhibitors in cancer cells: Mechanisms and potential clinical implications. Clin Cancer Res 2009, 15: 3947-3957.
    • (2009) Clin Cancer Res , vol.15 , pp. 3947-3957
    • Schrump, D.S.1
  • 21
    • 0032948005 scopus 로고    scopus 로고
    • Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
    • Cameron EE, Bachman KE, Myöhänen S, Herman JG, Baylin SB: Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999, 21: 103-107.
    • (1999) Nat Genet , vol.21 , pp. 103-107
    • Cameron, E.E.1    Bachman, K.E.2    Myöhänen, S.3    Herman, J.G.4    Baylin, S.B.5
  • 22
    • 0842322916 scopus 로고    scopus 로고
    • Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells
    • Lemaire M, Momparler LF, Farinha NJ, Bernstein M, Momparler RL: Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by phenylbutyrate on L1210 leukemic cells. Leukemia Lymphoma 2004, 45: 147-154.
    • (2004) Leukemia Lymphoma , vol.45 , pp. 147-154
    • Lemaire, M.1    Momparler, L.F.2    Farinha, N.J.3    Bernstein, M.4    Momparler, R.L.5
  • 24
    • 84986302942 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan D, Weinberg RL: Hallmarks of cancer: The next generation. Cell 2012, 44: 647-664.
    • (2012) Cell , vol.44 , pp. 647-664
    • Hanahan, D.1    Weinberg, R.L.2
  • 25
    • 34247625135 scopus 로고    scopus 로고
    • Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
    • Tan J, Yang X, Zhuang L, Jiang X, Chen W, Lee PL, Karuturi RK, Tan PB, Liu ET, Yu Q: Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Gene Develop 2007, 21: 1050-1063.
    • (2007) Gene Develop , vol.21 , pp. 1050-1063
    • Tan, J.1    Yang, X.2    Zhuang, L.3    Jiang, X.4    Chen, W.5    Lee, P.L.6    Karuturi, R.K.7    Tan, P.B.8    Liu, E.T.9    Yu, Q.10
  • 26
    • 67649371461 scopus 로고    scopus 로고
    • DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
    • Miranda TB, Cortez CC, Yoo CB, Liang G, Abe M, Kelly TK, Marquez VE, Jones PA: DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol Cancer 2009, 8: 1579-1588.
    • (2009) Mol Cancer , vol.8 , pp. 1579-1588
    • Miranda, T.B.1    Cortez, C.C.2    Yoo, C.B.3    Liang, G.4    Abe, M.5    Kelly, T.K.6    Marquez, V.E.7    Jones, P.A.8
  • 29
    • 0030938184 scopus 로고    scopus 로고
    • Pharmacological approach for optimization of the dose-schedule of 5-aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia
    • Momparler RL, Côté S, Eliopoulos N: Pharmacological approach for optimization of the dose-schedule of 5-aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia. Leukemia 1997, 11: 175-180.
    • (1997) Leukemia , vol.11 , pp. 175-180
    • Momparler, R.L.1    Côté, S.2    Eliopoulos, N.3
  • 31
    • 0022303520 scopus 로고
    • Clinical trial on 5-aza-2-deoxycytidine in patients with acute leukemia
    • Momparler RL, Rivard GE, Gyger M: Clinical trial on 5-aza-2-deoxycytidine in patients with acute leukemia. Pharmac Ther 1986, 30: 277-286.
    • (1986) Pharmac Ther , vol.30 , pp. 277-286
    • Momparler, R.L.1    Rivard, G.E.2    Gyger, M.3
  • 32
    • 0025807853 scopus 로고
    • The antileukaemic activity of 5-aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia
    • Richel DJ, Colly LP, Kluin-Nelemans JC, Willemze R: The antileukaemic activity of 5-aza-2 deoxycytidine (Aza-dC) in patients with relapsed and resistant leukaemia. Br J Cancer 1991, 64: 144-148.
    • (1991) Br J Cancer , vol.64 , pp. 144-148
    • Richel, D.J.1    Colly, L.P.2    Kluin-Nelemans, J.C.3    Willemze, R.4
  • 33
    • 78650175624 scopus 로고    scopus 로고
    • 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase
    • Raynal NJ, Momparler LF, Rivard GE, Momparler RL: 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase. Leuk Res 2010, 35: 110-118.
    • (2010) Leuk Res , vol.35 , pp. 110-118
    • Raynal, N.J.1    Momparler, L.F.2    Rivard, G.E.3    Momparler, R.L.4
  • 34
    • 84872389658 scopus 로고    scopus 로고
    • Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia
    • Claus R, Pfeifer D, Almstedt M, Zucknick M, Hackanson B, Plass C, Lübbert M: Decitabine induces very early in vivo DNA methylation changes in blasts from patients with acute myeloid leukemia. Leuk Res 2013, 37: 190-196.
    • (2013) Leuk Res , vol.37 , pp. 190-196
    • Claus, R.1    Pfeifer, D.2    Almstedt, M.3    Zucknick, M.4    Hackanson, B.5    Plass, C.6    Lübbert, M.7
  • 36
    • 77956288615 scopus 로고    scopus 로고
    • Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation
    • Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP: Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res 2010, 70: 6968-6977.
    • (2010) Cancer Res , vol.70 , pp. 6968-6977
    • Si, J.1    Boumber, Y.A.2    Shu, J.3    Qin, T.4    Ahmed, S.5    He, R.6    Jelinek, J.7    Issa, J.P.8
  • 37
    • 33645751058 scopus 로고    scopus 로고
    • Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state
    • McGarvey KM, Fahrner JA, Greene E, Martens J, Jenuwein T, Baylin SB: Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res 2006, 66: 3541-3549.
    • (2006) Cancer Res , vol.66 , pp. 3541-3549
    • McGarvey, K.M.1    Fahrner, J.A.2    Greene, E.3    Martens, J.4    Jenuwein, T.5    Baylin, S.B.6
  • 38
    • 73149085280 scopus 로고    scopus 로고
    • Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
    • Sun F, Chan E, Wu Z, Yang X, Marquez VE, Yu Q: Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. Mol Cancer Ther 2009, 8: 3191-3202.
    • (2009) Mol Cancer Ther , vol.8 , pp. 3191-3202
    • Sun, F.1    Chan, E.2    Wu, Z.3    Yang, X.4    Marquez, V.E.5    Yu, Q.6
  • 39
    • 84891854229 scopus 로고    scopus 로고
    • EZH2 in normal and malignant hematopoiesis
    • Lund K, Adams PD, Copland M: EZH2 in normal and malignant hematopoiesis. Leukemia 2014, 28: 44-49.
    • (2014) Leukemia , vol.28 , pp. 44-49
    • Lund, K.1    Adams, P.D.2    Copland, M.3
  • 41
    • 84857742284 scopus 로고    scopus 로고
    • DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory
    • Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estécio MR, Issa JP: DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res 2012, 72: 1170-1181.
    • (2012) Cancer Res , vol.72 , pp. 1170-1181
    • Raynal, N.J.1    Si, J.2    Taby, R.F.3    Gharibyan, V.4    Ahmed, S.5    Jelinek, J.6    Estécio, M.R.7    Issa, J.P.8
  • 43
    • 77951045228 scopus 로고    scopus 로고
    • Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML
    • Paul TA, Bies J, Small D, Wolff L: Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML. Blood 2010, 115: 3098-3108.
    • (2010) Blood , vol.115 , pp. 3098-3108
    • Paul, T.A.1    Bies, J.2    Small, D.3    Wolff, L.4
  • 47
    • 39749087580 scopus 로고    scopus 로고
    • P21(WAF1/CIP1) may be a tumor suppressor after all
    • Gartel AL: P21(WAF1/CIP1) may be a tumor suppressor after all. Cancer Biol Ther 2007, 6: 1171-1172.
    • (2007) Cancer Biol Ther , vol.6 , pp. 1171-1172
    • Gartel, A.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.